A number of firms have modified their ratings and price targets on shares of Helius Medical Technologies (NASDAQ: HSDT) recently: 6/8/2022 – Helius Medical Technologies was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $2.25 price target on the stock. According to Zacks, “Helius […]